Related Experiment Videos
Matrix metalloproteinases and cancer.
1Department of Medical Oncology, Leicester Royal Infirmary, UK.
Anticancer Research
|March 23, 2002
Summary
The extracellular matrix (ECM) is crucial for tissue structure and cancer progression. Matrix metalloproteinases (MMPs) degrade the ECM, promoting tumor invasion and angiogenesis, making them key therapeutic targets.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- The extracellular matrix (ECM) provides structural integrity to tissues.
- ECM remodeling is vital for tumor invasion and angiogenesis.
- Matrix metalloproteinases (MMPs) are key enzymes involved in ECM degradation.
Purpose of the Study:
- To review the regulation of MMP expression.
- To examine the association of MMPs with tumor growth, invasion, and angiogenesis.
- To discuss the clinical development of MMP inhibitors.
Main Methods:
- Literature review of existing research on MMPs and cancer.
- Analysis of studies on MMP regulation and function.
- Examination of clinical trial data for MMP inhibitors.
Main Results:
- MMPs play a significant role in promoting tumor invasion and angiogenesis.
- Regulation of MMP expression is complex and multifaceted.
- MMP inhibitors show potential for cancer therapy, alone or with cytotoxic treatments.
Conclusions:
- MMPs are critical mediators of tumor progression.
- Targeting MMPs offers a promising therapeutic strategy for cancer treatment.
- Further research and clinical evaluation of MMP inhibitors are warranted.